Off-pump coronary artery revascularization in octogenarians: Is it better?

Current Opinion in Cardiology

Volumn 24, Issue 6, 2009, Pages 544-552

  Cartier, Raymond ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Coronary artery disease; Octogenarians; Off pump coronary artery bypass surgery

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIURETIC AGENT; HEPARIN;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DELIRIUM; DEMOGRAPHY; GRAFT PATENCY; HEART ATRIUM FIBRILLATION; HUMAN; INVASIVE PROCEDURE; KIDNEY FAILURE; MEDICAL LITERATURE; POPULATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SOCIETY; STROKE; SURGEON; SURGICAL MORTALITY; SURGICAL RISK; SYSTOLIC HYPERTENSION;

EID: 74249090592     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32833124f5     Document Type: Review

References (144)

1. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26:2714-2720.
2. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82:2111-2115.
3. Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007; 28:1358-1365.
4. Institut de la statistique du Qué bec. Perspectives démographiques, Québec et ré gions, 2001-2051. 2003 ed.; 2003. http://www.stat.gouv.qc.ca/donstat/societe/demographie/persp-poplt/index. htm.
5. Statistical abstract of the United States/1991(11th ed). Washington, District of Columbia: Department of Commerce, US Bureau of the Census; 1991. p. 81.
6. National Center for Health Statistics. Vital health statistic of the United States 1989. Vol.2. Washington, District of Columbia: US Government Printing Office; 1992. p. 11.
7. National Center for Health Statistics. Current estimate from the National Health Interview Survey 1989: vital health statistics, series 10. Washington, District of Columbia: US Government Printing Office; 1990. No.176.
8. Centers for Disease Control and Prevention. Trends in aging: United States and worldwide. MMWR Morb Mortal Wkly Rep 2003; 52:101-104, 106.
9. Granger CB, Goldberg RJ, Dabbous O, et al., Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 2003; 163:2345-2353.
10. The future of CVD. In: Mackay J, Mensah G, editors. The atlas of heart disease and stroke. Geneva, Switzerland: World Heath Organization; 2004:74-75. http://www.who.int/cardiovascular-diseases/en/cvdatlas25future.pdf. [Accessed 10 June 2005].
11. Avezum A, Makdisse M, Spencer F, et al., GRACE Investigators. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005; 140:67-73.
12. Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286:708-713.
13. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990; 322:213-217. (Pubitemid 20034507)
14. Pan WH, Cedres LB, Liu K, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease in men and women. Am J Epidemiol 1986; 123:504-516.
15. Iso H, Jacobs DR Jr, Wentworth D, et al. Serum cholesterol levels and sixyear mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989; 320:904-910.
16. Cupples LA, D'Agostino RB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30-year follow-up [section 34]. In: Kannel WB, Wolf PA, Garrison RJ, editors. The Framingham Study: an epidemiological investigation of cardiovascular disease. Bethesda, Maryland: National Institutes of Health; 1987. NIH publication 87-2703.
17. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 1997; 277:739-745.
18. Gould AL, Rossouw JE, Santanello NC, et al. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 1998; 97:946-952.
19. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304:405-412.
20. Rubin SM, Sidney S, Black DM, et al. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med 1990; 113:916-920.
21. Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med 1993; 153:1065-1073.
22. Garber AM, Browner WS. Cholesterol screening guidelines: consensus, evidence and common sense. Circulation 1997; 95:1642-1645.
23. Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 1989; 110:101-107.
24. O'Leary DH, Polak JF. High-resolution carotid sonography: past, present, and future. AJR Am J Roentgenol 1989; 153:699-704.
25. Psaty BM, Furberg CD, Kuller LH, et al. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med 1999; 159:1339-1347.
26. Abraira C, Colwell J, Nuttall F, et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Arch Intern Med 1997; 157:181-188.
27. Curb JD, Pressel SL, Cutler JA, et al., for the Systolic Hypertension in the Elderly Program Cooperative Research Group. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 276:1886-1892.
28. Smith SC Jr, Gilpin E, Ahnve S, et al. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. J Am Coll Cardiol 1990; 16:784-792.
29. Aronow WS. Management of elderly person after myocardial infarction. J Gerontol A Biol Sci Med Sci 2004; 59:1173-1185.
30. Jajich CL, Ostfeld AM, Freeman DH Jr. Smoking and coronary heart disease mortality in the elderly. JAMA 1984; 252:2831-2834.
31. Siegel D, Kuller L, Lazarus NB, et al. Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program pilot project. Am J Epidemiol 1987; 126:385-399.
32. Kannel WB, Vokonas PS, Wenger NK, Furberg CD, Pitt B, editors. Coronary heart disease in the elderly. New York: Elsevier Science Publishing Co.; 1986. pp. 60-92.
33. Hermanson B,Omenn GS, KronmalRA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 1988; 319:1365-1369.
34. Aronow WS, Ahn C. Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease. Am J Cardiol 1996; 77:864-866.
35. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289:2560-2572.
36. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100:1016-1030.
37. Aronow WS, Ahn C, Kronzon I. Effect of beta blockers alone, of angiotensinconverting enzyme inhibitors alone, and of beta blockers plus angiotensinconverting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction. Am J Cardiol 2001; 88:1298-1300.
38. Aronow WS, Ahn C. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and diabetes mellitus. Am J Cardiol 2001; 87:780-781. (Pubitemid 32209099)
39. Aronow WS, Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers. Am J Cardiol 2002; 89:1207-1209.
40. Aronow WS. What is the appropriate treatment of hypertension in elders? J Gerontol A Biol Sci Med Sci 2002; 57A:M483-M486.
41. Aronow WS, Ahn C. Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statins. Heart Dis 2002; 4:159-161.
42. Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2001; 38:1581-1583.
43. Kannel WB, Cupples LA, Ramaswami R, et al. Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol 1991; 44:183-190.
44. Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5-year risk of death in older women. JAMA 1993; 269:483-487.
45. Williams MA, Maresh CM, Aronow WS, et al. The value of early out-patient cardiac exercise programmes for the elderly in comparison with other selected age groups. Eur Heart J 1984; 5 (Suppl E):113-115.
46. Aronow WS. Exercise therapy for older persons with cardiovascular disease. Am J Geriatr Cardiol 2001; 10:245-252.
47. Greene HL, The CASCADE study. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am J Cardiol 1993; 72:70F-74F.
48. Herre JM, Sauve MJ, Malone P, et al. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 1989; 13:442-449.
49. Waldo AL, Camm AJ, deRuyter H, et al., the SWORD Investigators. Effect of D-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348:7-12.
50. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993; 270:1589-1595.
51. Aronow WS, Mercando AD, Epstein S, Kronzon I. Effect of quinidine or procainamide versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in elderly patients with heart disease and complex ventricular arrhythmias. Am J Cardiol 1990; 66:423-428.
52. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997; 277:115-121.
53. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S, The Adverse Experience Committee, and the Multicenter Diltiazem Postinfarction Research Group. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991; 83:52-60.
54. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988; 319:385-392.
55. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.
56. The TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet 2001; 358:951-957
57. Aronow WS. Approach to symptomatic coronary disease in the elderly: TIME to change? Lancet 2001; 358:945-946.
58. Gurwitz JH, Goldberg RJ, Chen Z, et al. Recent trends in hospital mortality of acute myocardial infarction: the Worcester Heart Attack Study - have improvements been realized for all age groups? Arch Intern Med 1994; 154:2202-2208.
59. Bertrand ME, Simoons ML, Fox KA, et al., Task Force on the management of acute coronary syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002; 23:1809-1840.
60. Braunwald E, Antman EM, Beasley JW, et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the management of patients with unstable angina). Circulation 2002; 106:1893-1900.
61. Alexander KP, Roe MT, Chen AY, et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005; 46:1479-1487.
62. Pfisterer M, Buser P, Osswald S, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA 2003; 289:1117-1123.
63. Graham MM, Ghali WA, Faris PD, et al., Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators. Survival after coronary revascularization in elderly. Circulation 2002; 105:2378-2384.
64. Zingone B, Gatti G, Rauber E, et al. Early and late outcomes of cardiac surgery in octogenerians. Ann Thorac Surg 2009; 87:71-78.
65. Maganti M, Rao V, Brister S, Ivanov J. Decreasing mortality for coronary artery bypass surgery in octogenarians. Can J Cardiol 2009; 25:e32-e35. This is an interesting study documenting the decrease mortality and morbidity in the elderly population over the last decade even though they were subjected to more comorbidity.
66. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373:1190-1197. This an interesting meta-analysis reviewing 10 randomized prospective trials comparing CABG surgery and PCI showing advantage of CABG for older and diabetic patients.
67. Tugtekin S, Kappert U, Alexiou K, et al. Coronary artery bypass grafting in octogenarians: outcome with and without extracorporeal circulation. Thorac Cardiovasc Surg 2007; 55:407-411.
68. Gummert JF, Funkat A, Beckmann A, et al., German Society for Thoracic and Cardiovascular Surgery. Cardiac surgery in Germany during 2007: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2008; 56:328-336.
69. Dacey LJ, Likosky DS, Ryan TJ Jr, et al., Northern New England Cardiovascular Disease Study Group. Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease. Ann Thorac Surg 2007; 84:1904-1911.
70. Oxman TE, Freeman DH Jr, Manheimer ED. Lack of social participation or religious strength and comfort as risk factors for death after cardiac surgery in the elderly. Psychosom Med 1995; 57:5-15.
71. Rumsfeld JS, MaWhinney S, McCarthy M Jr, et al. Heath-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures and Outcomes of Care in Cardiac Surgery. JAMA 1999; 281:1298-1303.
72. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomised Coronary Artery Surgery Study. Circulation 1990; 82:1629-1646.
73. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992; 326:10-16.
74. Rihal CS, Gersh BJ, Yusuf S. Chronic coronary artery disease: coronary artery bypass surgery versus percutaneous transluminal coronary angioplasty versus medical therapy. In: Yusuf S, Cairns JA, Camm AJ, et al., editors. Evidence based cardiology. London: BMJ Books; 1999. pp. 368-392.
75. Rastan AJ, Walther T, Falk V, et al. Off-pump coronary artery bypass grafting. State of the art 2006 and results in comparison with conventional coronary artery bypass strategies [in German]. Herz 2006; 31:384-395.
76. van Dijk D, Nierich AP, Jansen EW, et al., Octopus Study Group. Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation 2001; 104:1761-1766.
77. Angelini GD, Taylor FC, Reeves BC, Ascione R. Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials. Lancet 2002; 359:1194-1199.
78. Puskas JD, Williams WH, Duke PG, et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125:797-808.
79. Nathoe HM, van Dijk D, Jansen EW, et al., Octopus Study Group. A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med 2003; 348:394-402. (Pubitemid 36159356)
80. Khan NE, De Souza A, Mister R, et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 2004; 350:21-28.
81. Widimsky P, Straka Z, Stros P, et al. One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial. Circulation 2004; 110:3418-3423.
82. Kobayashi J, Tashiro T, Ochi M, et al., Japanese Off-Pump Coronary Revascularization Investigation (JOCRI) Study Group. Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization. Circulation 2005; 112 (9 Suppl):I338-I343.
83. Al-Ruzzeh S, George S, Bustami M, et al. Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: randomised controlled trial. Br Med J 2006; 332:1365.
84. Panesar SS, Chikwe J, Mirza SB, et al. Off-pump coronary artery bypass surgery may reduce the incidence of stroke in patients with significant left main stem disease. Thorac Cardiovasc Surg 2008; 56:247-255. A meta-analysis including nine studies comparing on and off-pump cases with significant left main stenosis showing a significant advantage for OPCAB surgery regarding postoperative strokes.
85. Parolari A, Alamanni F, Cannata A, et al. Off-pump versus on-pump coronary artery bypass: meta-analysis of currently available randomized trials. Ann Thorac Surg 2003; 76:37-40.
86. Feng ZZ, Shi J, Zhao XW, Xu ZF. Meta-analysis of on-pump and off-pump coronary arterial revascularization. Ann Thorac Surg 2009; 87:757-765.
87. Wijeysundera DN, Beattie WS, Djaiani G, et al. Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. J Am Coll Cardiol 2005; 46:872-882.
88. Nigwekar SU, Kandula P, Hix JK, Thakar CV. Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized and observational studies. Am J Kidney Dis 2009 [Epub ahead of print]. This is the most important meta-analysis addressing the issue of postoperative acute renal failure in patients operated on and off-pump.
89. Hannan EL,WuC, Smith CR, et al. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation 2007; 116:1145-1152.
90. Al-Ruzzeh S, Ambler G, Asimakopoulos G, et al., United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome. Off-pump coronary artery bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: a United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome. Circulation 2003; 108 (Suppl 1):II1-II8.
91. Puskas JD, Williams WH, Mahoney EM, et al. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA 2004; 291:1841-1849.
92. Parolari A, Alamanni F, Polvani G, et al. Meta-analysis of randomized trials comparing off-pump with on-pump coronary artery bypass graft patency. Ann Thorac Surg 2005; 80:2121-2125.
93. Cho KR, Jeong DS, Kim KB. Influence of vein graft use on postoperative 1-year results after off-pump coronary artery bypass surgery. Eur J Cadiothorac Surg 2007; 32:718-723.
94. Onorati F, Olivito S, Mastroroberto P, et al. Perioperative patency of coronary artery bypass grafting is not influenced by off-pump technique. Ann Thorac Surg 2005; 80:2132-2140.
95. Angelini GD, Culliford L, Smith DK, et al. Effects of on- and off-pump coronary artery surgery on graft patency, survival, and health-related quality of life: longterm follow-up of 2 randomized controlled trials. J Thorac Cardiovasc Surg 2009; 137:295-303. A very important study reporting long-term experience with two randomized trials showing the same clinical outcome and also the same graft patency with both techniques confirming that in good hands on and off-pump surgery can be performed with comparable efficiency.
96. Konety SH, Rosenthal GE, Vaughan-Sarrazin MS. Surgical volume and outcomes of off-pump coronary artery bypass graft surgery: does it matter? J Thorac Cardiovasc 2009; 137:1116-1123. This is an important large observational study including 124 Californian hospitals and over 100 000 CABG patients. The hospitals with the highest rate of off-pump surgery showed significantly better outcome with OPCAB, whereas no significant difference was recorded in those with low caseload.
97. Murphy GJ, Rogers CA, Caputo M, Angelini GD. Acquiring proficiency in offpump surgery: traversing the learning curve, reproducibility, and quality control. Ann Thorac Surg 2005; 80:1965-1970.
98. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 1998; 128:194-203.
99. Amar D, Zhang H, Leung DH, et al. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology 2002; 96:352-356.
100. Stamou SC, Dangas G, Dullum MK, et al. Beating heart surgery in octogenarians: perioperative outcome and comparison with younger age groups. Ann Thorac Surg 2000; 69:1140-1145.
101. Guru V, Glasgow KW, Fremes SE, et al. The real-world outcomes of off-pump coronary artery bypass surgery in a public healthcare system. Can J Cardiol 2007; 23:281-286.
102. Ricci M, Karamanoukian HL, Dancona G, et al. On-pump and off-pump coronary artery bypass grafting in the elderly: predictors of adverse outcome. J Card Surg 2001; 16:458-466.
103. Athanasiou T, Al-Ruzzeh S, Kumar P, et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg 2004; 77:745-753.
104. Guerra M, Carlos Mota J. Adult cardiac surgery: impact on age group differences in preoperative risk factors and early mortality. Rev Port Cir Cardiotorac Vasc 2008; 15:189-195.
105. Scott BH, Seifert FC, Grimson R, Glass PS. Octogenarians undergoing coronary artery bypass graft surgery: resource utilization, postoperative mortality, and morbidity. J Cardiothorac Vasc Anesth 2005; 19:583-588.
106. Panesar SS, Athanasiou T, Nair S, et al. Early outcomes in the elderly: a metaanalysis of 4921 patients undergoing coronary artery bypass grafting - comparison between off-pump and on-pump techniques. Heart 2006; 92:1808-1816.
107. Kerendi F, Morris CD, Puskas JD. Off-pump coronary bypass surgery for high-risk patients: only in expert centers? Curr Opin Cardiol 2008; 23:573-578.
108. Norkiene I, Ringaitiene D, Misiuriene I, et al. Incidence and precipitating factors of delirium after coronary artery bypass grafting. Scand Cardiovasc J 2007; 41:180-185.
109. Bucerius J,Gummert JF, Borger MA, et al. Predictors of delirium after cardiac surgery delirium: effect of beating-heart (off-pump) surgery. J Thorac Cardiovasc Surg 2004; 127:57-64.
110. Rolfson DB, McElhaney JE, Rockwood K, et al. Incidence and risk factors for delirium and other adverse outcomes in older adults after coronary artery bypass graft surgery. Can J Cardiol 1999; 15:771-776.
111. Ascione R, Ghosh A, Reeves BC, et al. Retinal and cerebral microembolization during coronary artery bypass surgery: a randomized, controlled trial. Circulation 2005; 112:3833-3838.
112. Fearn SJ, Pole R, Wesnes K, et al. Cerebral injury during cardiopulmonary bypass: emboli impair memory. J Thorac Cardiovasc Surg 2001; 121:1150-1160.
113. Meyendorf R. Psychopatho-ophthalmology, gnostic disorders, and psychosis in cardiac surgery. Visual disturbances after open heart surgery. Arch Psychiatr Nervenkr 1982; 232:119-135.
114. Meyendorf R. Cerebral embolism and psychosis with special reference to cardiac surgery. J Neurol 1976; 213:163-177.
115. Stroobant N, Van Nooten G, Van Belleghem Y, Vingerhoets G. Relation between neurocognitive impairment, embolic load, and cerebrovascular reactivity following on- and off-pump coronary artery bypass grafting. Chest 2005; 127:1967-1976.
116. Diegeler A, Hirsch R, Schneider F, et al. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation. Ann Thorac Surg 2000; 69:1162-1166.
117. Zamvar V, Williams D, Hall J, et al. Assessment of neurocognitive impairment after off-pump and on-pump techniques for coronary artery bypass graft surgery: prospective randomised controlled trial. BMJ 2002; 325:1268-1272.
118. Lee JD, Lee SJ, Tsushima WT, et al. Benefits of off-pump bypass on neurologic and clinical morbidity: a prospective randomized trial. Ann Thorac Surg 2003; 76:18-25.
119. Van Dijk D, Jansen EW, Hijman R, et al., Octopus Study Group. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. JAMA 2002; 287:1405-1412.
120. Jensen BO, Hughes P, Rasmussen LS, et al. Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting: a randomized trial. Circulation 2006; 113:2790-2795. (Pubitemid 44305290)
121. van Dijk D, Spoor M, Hijman R, et al., Octopus Study Group. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA 2007; 297:701-708.
122. Selnes OA, McKhann GM. Neurocognitive complications after coronary artery bypass surgery. Ann Neurol 2005; 57:615-621.
123. Ganushchak YM, Fransen EJ, Visser C, et al. Neurological complications after coronary artery bypass grafting related to the performance of cardiopulmonary bypass. Chest 2004; 125:2196-2205.
124. Mathew JP, Mackensen GP, Phillips-Bute B, et al., Neurologic Outcome Research Group (NORG) of the Duke Heart Center. Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly. Anesthesiology 2007; 107:577-584.
125. Borger MA, Feindel CM. Cerebral emboli during cardiopulmonary bypass: effect of perfusionist interventions and aortic cannulas. J Extra Corpor Technol 2002; 34:29-33.
126. Newman MF, Kirchner JL, Phillips-Bute B, et al., The Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Eng J Med 2001; 344:395-402.
127. Phillips-Bute B, Mathew JP, Blumenthal JA, et al. Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med 2006; 68:369-375.
128. Loponen P, Luther M, Wistbacka JO, et al. Postoperative delirium and health related quality of life after coronary artery bypass grafting. Scand Cardiovasc J 2008; 42:337-344.
129. Selnes OA, Grega MA, Borowicz LM Jr, et al. Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg 2003; 75:1377-1384.
130. Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997; 226:501-511.
131. Akazawa T, Nishihara H, Iwata H, et al. Preoperative plasma brain natriuretic peptide level is an independent predictor of postoperative atrial fibrillation following off-pump coronary artery bypass surgery. J Anesth 2008; 22:347-353.
132. Athanasiou T, Aziz O, Mangoush O, et al. Do off-pump techniques reduce the incidence of postoperative atrial fibrillation in elderly patients undergoing coronary artery bypass grafting? Ann Thorac Surg 2004; 77:1567-1574. (Pubitemid 38529983)
133. Athanasiou T, Aziz O, Mangoush O, et al. Does off-pump coronary artery bypass reduce the incidence of postoperative atrial fibrillation? A question revisited. Eur J Cardiothorac Surg 2004; 26:701-710. (Pubitemid 39273567)
134. Daniel K, Wolfe CD, Busch MA, McKevitt C. What are the social consequences of stroke for working-aged adults? A systematic review. Stroke 2009; 40:e431-e440.
135. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001; 32:280-299. (Pubitemid 32063861)
136. Alexander KP, Anstrom KJ, Muhlbaier LH, et al. Outcomes of cardiac surgery in patients ≥80 years: results from the National Cardiovascular Network. J Am Coll Cardiol 2000; 35:731-738.
137. Roberts CS, Gorelick PB, Ye X, et al. Additional stroke-related and nonstroke-related cardiovascular costs and hospitalizations in managed-care patients after ischemic stroke. Stroke 2009; 40:1425-1432.
138. Nishiyama K, Horiguchi M, Shizuta S, et al. Temporal pattern of strokes after on-pump and off-pump coronary artery bypass graft surgery. Ann Thorac Surg 2009; 87:1839-1844. An important study on early and delayed cerebrovascular accident (CVA) after CABG surgery showing a significant decrease in early CVA in OPCAB patients suggesting a benefit related to lesser aortic manipulations.
139. Sharony R, Grossi EA, Saunders PC, et al. Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease. J Thorac Cardiovasc Surg 2004; 127:406-413.
140. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996; 335:1857-1863.
141. Hosoda Y, Watanabe M, Hirooka Y, et al. Significance of atherosclerotic changes of the ascending aorta during coronary bypass surgery with intraoperative detection by echography. J Cardiovasc Surg (Torino) 1991; 32:301-306.
142. Davila-Roman VG, Murphy SF, Nickerson NJ, et al. Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality. J Am Coll Cardiol 1999; 33:1308-1316.
143. Wareing TH, Davila-Roman VG, Daily BB, et al. Strategy for the reduction of stroke incidence in cardiac surgical patients. Ann Thorac Surg 1993; 55:1400-1407.
144. Weerasinghe A, Athanasiou T, Al-Ruzzeh S, et al. Functional renal outcome in on-pump and off-pump coronary revascularization: a propensity-based analysis. Ann Thorac Surg 2005; 79:1577-1583.